Skip to main content

Join us Feb. 13 at 11 a.m. ET for “Breaking Barriers with Digital Health Technologies,” unveiling new resources to advance CRS risk prediction and support DHT development. Don’t miss it!

Take the fast track to becoming a V3 and V3+ expert

Amy A. Speaks on V3

“At Verily we used DiMe resources to build both internal and external vernacular and a structured way of presenting information that lined up with [V3]…this gave us the tooling that we needed so we could move fast.” – Amy Abernethy, MD, PhD, President, Clinical Studies Platforms, Verily